Hpv Article Critique : Human Papilloma Virus ( Hpv )

HPV is so common in the United States that nearly all men and women will contract the virus at some point during life (Center for Disease Control and Prevention [CDC], 2017). In the United States, in 2008, it is reported that 3.2 million, or one in four adolescent women, ages 14 to 19 have had or have an STD (Kostas-Polston et al., 2012). The rate of HPV cases has only increased since 2008. The prevalence of a genital infection with any HPV type was 42.5% among United States during 2013–2014 (CDC, 2017). The incidence of HPV in the United States is about 14 million people each year.

Prophylactic vaccination against high risk human papilloma virus 16 and 18 represents an exciting means of protection against HPV related malignancy. However, this strategy alone, even if there is a level of cross protection against other oncogenic viruses, cannot completely prevent cervical cancer. In some countries cervical screening programs have reduced the incidence of invasive cervical cancer by up to 80 percent although this decline has now reached a plateau with current cancers occurring in patients who have failed to attend for screening or where the sensitivity of the tests have proved inadequate. Cervical screening is inevitably associated with significant anxiety for the many women who require investigation and treatment following abnormal cervical cytology. However, it is vitally important to stress the need for continued cervical screening to complement vaccination in order to optimize prevention in vaccines and prevent cervical cancer in older women where the value of vaccination is currently unclear. It is likely that vaccination will ultimately change the natural history of HPV disease by reducing the influence of the highly oncogenic types HPV 16 and 18. In the long term this is likely to lead to an increase in recommended screening intervals. HPV vaccination may also reduce

Human papillomavirus (HPV) infection is a widespread sexually transmitted infection. Approximately 14 million Americans are infected with HPV each year ("HPV Vaccine for Preteens and Teens,"). HPV also causes several types of cancers, such as vaginal cancer and anal cancer. More than 27,000 women and men are affected by a HPV-related cancer annually ("The Link Between HPV and Cancer,"). The most common HPV cancers for women and men are cervical cancer, and oral cavity and oropharyngeal cancers, respectively. Research has demonstrated that many cancers caused by HPV can be prevented by the HPV vaccine, which is administered in 3 doses over 6 months ("The

Human Papillomavirus(HPV) is the most common sexually transmitted infection in the United States, according to Centers for Disease Control and Prevention(CDC) around 20 million people are infected with HPV and additional 6.2 million people are newly infected every year. According to National Health and Nutrition Examination Survey in 2003-2004 among sexually active women (57% of 14 to 19 years and 97% of 20 to 59 years) HPV was highest prevalent in youngest age group (40% of 14-19 years and 50% of 20-24 years). Infection rates decrease after age of 24 years. There are more than 100 types of HPV viruses out of which 40 cause genital infections. Out of

As the Center for Disease Control (CDC) (2015) confirms, human papillomavirus (HPV) is the most common sexually transmitted infection (STD or STI) among men and women; it is so common that nearly every sexually active individual will get it at some point in their lives. With about 14 million new cases each year, the CDC (2015) reports a prevalence of about 79 million cases of persons currently infected with HPV in the United States (US). Also, with cervical cancer being the most serious outcome related to HPV, the state of Georgia falls in the mid-interval of 6.66 to 7.87 with HPV-related cervical cancer per 100,000 people. It is evident that this disease is more prevalent in rural areas and among underserved populations. HPV is actually

Human papillomavirus (HPV) is the most common sexually transmitted disease (STD) and can affect many sexually active individuals throughout their lifetimes and is spread through anal, oral and vaginal sex (CDC, 2016). HPV currently affects 79 million Americans with 14 million new cases of infection every year and is so pervasive most sexually-active individuals will encounter some form of the virus during their lives (CDC, 2016). HPV can be troublesome to detect as symptoms can develop years after initial infection or may not be seen at all, but in many cases HPV does not cause lasting health problems (CDC, 2016).

Human Papilloma Virus, known to most people as HPV, is an infectious disease that has become one of top causes of cervical cancer in women. With shocking surge in HPV prevalence, researchers are encouraged to discover more about this virus and how it leads to cervical cancer. Until recently, not many knew what HPV was; there hasn’t been enough research conducted on the virus. In fact, HPV was not significant enough to be taught in the Sexual Education classrooms as an Sexually Transmitted Infection (STI). Years of research yielded information about how one contracts the virus, the symptoms or lack of symptoms, treatment and prevention for HPV.

Human Papillomavirus (HPV) is a sexually transmitted virus that spreads from person to person by direct contact of infected tissue. According to the CDC, nearly all men and women will contract HPV at some point in their life (Centers for Disease Control and Prevention [CDC], 2013). HPV can cause cervical, vaginal and vulvar cancers in females. HPV can also cause anal, throat, and neck cancer in both males and females. HPV is also known to cause genital warts in both males and females. According to the National Cancer Institute (2013), “approximately 12,340 new cases of cervical cancer will be diagnosed in the US, and 4,030 US women will die

HPV, human papillomavirus is a communal infection that is common among adults. It is one of the main sources of sexual transmitted infection. Over 75% of women that are sexually active are most likely to be infected at least once in their life. This virus is known to be a worldwide disease. According to the World Health Organization, the risk of acquiring HPV infection is highest soon after a sexual encounter. Most of these infections are self-limiting and harmless. The virus is harmless because a number of people don’t realize they are infected, because the virus is often subclinical. Persistent infections with oncongenic HPV types can cause cervical cancer in women. Even though, both male and female can be affected by the

The advent of new human papilloma virus (HPV) vaccines with the potential to prevent the majority of cases of invasive cervical cancer presents a remarkable public health achievement (Markowitz et al., 2007). This is because cervical cancer is the commonest female cancer worldwide and it has been associated with HPV infection (Franceschi et al., 2009). In just 2015, there will be 12,900 new cases of cervical cancer in the United States with 4,100 estimated deaths (Siegel, Miller, & Jemel, 2015).

Human papilloma virus (HPV) is a name derived from group of viruses that affect the human skin and other moist areas found in the human body, such as the cervix, anus, mouth and throat. There are more than 100 species of HPV, of which only thirty of them affect the genital area. Genital HPV is very contagious and are spread during sexual intercourse and skin to skin of the genital areas. Some HPV can be physically detected, when there are visible genital warts seen around the site. HPV that do not exhibit clinical symptoms are known as sub-clinical HPV, which connotes that they are not visible, neither do they have recognizable symptoms (Women 's health specialist, November, 2009). Most of the time, Sub - clinical HPV is discovered when there is an abnormal results from pap smear. On the other hand, research also shows that men do encounter sub-clinical HPV, but the test does not work for them. Therefore, men may have it without knowing.

Human papillomavirus (HPV) is one of the most common sexually transmitted viral infections in the United States. There are nearly 1 out of 4 women who have been diagnosed with HPV (CDC, 2015). The Centers for Disease Control and Prevention (CDC) reported that at least 80% of women acquire a genital HPV infection by the age of 50 (CDC, 2015). HPV is an important topic that needs to be discussed because it has been estimated that 6.2 million cases of HPV has been reported (CDC, 2015). HPV is one third of all new sexual transmitted infections (CDC, 2015).

Among the many arguments for mandatory HPV vaccination, the foremost is that it is an important medical achievement and a major public health milestone. This vaccine has proven to be one-hundred percent effective in preventing the 4 HPV strains that are responsible for seventy percent of cervical cancers and ninety percent of genital warts. In addition, no serious side effects have been identified. Because this vaccine is a preventive measure, administration before onset of sexual activity is ideal; however, even females who have been sexually active can still benefit from this vaccination (Perkins et al., 2010). Nationally and internationally, the HPV vaccine will significantly reduce disease burden by reducing monetary and psychological costs of invasive procedures that remove precancerous and cancerous lesions. By combining vaccination with routine Pap smear screening, these public health efforts have the remarkable opportunity to eradicate cervical cancer (Ramet et al., 2011).

According to the National Cancer Institute, there were an estimated 12,360 new cases of cervical cancer and 4020 deaths in 2014. Seventy percent of these cases were caused by the human papillomavirus (HPV). HPV is a virus “spread by skin-to-skin contact” (Alexander, et al. 199). This virus can cause warts on the hands, feet, genital areas, of which 90% are caused from HPV, but in addition to cervical cancer, it may also cause cancer in many other parts of the body including head, neck, anal, and penial (Krishnan 2). All of this sounds pretty scary, however, much of it could be avoided with a simple series of HPV vaccinations. All of

In the United States, it is one of the eight-most common cancer of women. According to researches, the data shows that Hispanic women are significantly more likely to be diagnosed with cervical cancer than the general population and their median age at diagnosis is 48. In 1998, about 12,800 women were diagnosed in the US and about 4,800 died. Among cancers of the female reproductive tract, it is less common than endometrial cancer and ovarian cancer. The rates of new cases in the United States was 7 per 100,000 women in 2004. Cervical cancer deaths decreased by approximately 74% in the